Skip to main content

Caribou Biosciences, INC

Berkeley, CA
United States

TAP Partner

Caribou is a clinical-stage biotechnology company, co-founded by CRISPR pioneer and Nobel Prize winner Jennifer Doudna, Ph.D., using next-generation CRISPR genome-editing technology to develop “off-the-shelf” (allogeneic) CAR therapies for hard-to-treat blood cancers.

Program Name(s)
Therapy Acceleration Program
Caribou